Nutrition & Lifestyle
    Retatrutide

    Retatrutide and Meal Prep

    Retatrutide and meal prep go hand in hand for treatment success. When triple-agonist therapy suppresses your appetite (Jastreboff et al., NEJM 2023), the last thing you want is to stand in front of the stove deciding what to cook. Having protein-rich, nutrient-dense meals already prepared and portioned removes the friction that leads to skipped meals, inadequate protein, and poor nutritional choices. Meal prep is not just convenient on GLP-1 treatment -- it is essential.

    Published: April 3, 202611 min read

    Meal prep takes on a different character during GLP-1 treatment. Instead of preparing large quantities of food for a week of normal eating, you are preparing small, protein-focused portions designed to maximize nutrition in minimal volume. The goal is not to fill containers with food but to ensure that protein-rich options are always within arm's reach -- in the fridge, in your bag, at your desk -- so that when a window of appetite opens, you can immediately use it to nourish your body.

    Nutritional Guidance

    Retatrutide is not FDA-approved for any indication. Compounded semaglutide ($99/mo) and tirzepatide ($125/mo) are available now.

    Sunday Meal Prep Session (60-90 Minutes)

    A single weekly prep session can set you up for success:

    • Bake 1.5 lbs chicken breast: Season simply, slice, and portion into 4-oz containers (31g protein each). Refrigerate 3 days' worth, freeze the rest.
    • Hard-boil 12 eggs: Peel and store in the fridge. Grab-and-go protein (6g each) all week.
    • Cook 1 lb ground turkey: Season with garlic and herbs. Portion into containers. Use over salads, in wraps, or as snacks.
    • Prep vegetable bags: Wash, chop, and bag broccoli, bell peppers, and cucumber for easy sides.
    • Portion Greek yogurt: Divide large containers into individual servings (1/2-3/4 cup each).
    • Mix protein shake supplies: Pre-measure protein powder into individual bags/containers for quick blending.

    The Freezer Is Your Best Friend

    Because GLP-1 appetite varies day to day, fresh food often goes bad before it can be eaten. The freezer solves this problem. Freeze individual portions of cooked chicken, turkey, and fish. Frozen vegetables (steam-in-bag) are just as nutritious as fresh and never spoil. Protein smoothie packs (pre-measured protein powder, frozen banana, spinach in individual bags) make blending effortless. And frozen portions can be thawed in the fridge overnight or microwaved in minutes when appetite appears.

    Zero-Effort Backup Options

    For days when even reheating feels like too much, keep these on hand: protein shakes (ready-to-drink bottles), string cheese, jerky or turkey sticks, protein bars, cottage cheese cups, and canned tuna or chicken (single-serve pouches). These require zero preparation and provide essential protein when cooking energy is nonexistent.

    Portioning for GLP-1 Appetites

    Use smaller containers than you normally would. A 4-oz portion of protein with 1/2 cup vegetables is a substantial meal during GLP-1 treatment. Having pre-portioned containers prevents the discouragement of seeing a large plate of food you cannot finish. Small containers also make it easy to grab multiple small meals throughout the day rather than sitting down to overwhelming large plates. See our 7-day meal plan for portion guidance.

    Medical Disclaimer

    This article is for informational purposes only and does not constitute medical or nutritional advice. Retatrutide is not FDA-approved for any indication. Follow food safety guidelines for storage and reheating. Consult a registered dietitian for personalized meal planning.

    Set Yourself Up for Success

    Compounded semaglutide from $99/mo. Compounded tirzepatide from $125/mo. Physician-supervised weight loss.

    View Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the published clinical evidence show for retatrutide?

    Peer-reviewed evidence: Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial — the highest published mean weight reduction for any GLP-1-class agent in obesity to date. (Source: Jastreboff et al. Phase 2 trial, NEJM 2023). Trimi is preparing for launch; compounded availability depends on FDA-cleared compounding pathways. Results vary by individual; eligibility is determined by a licensed clinician.

    Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial — the highest published mean weight reduction for any GLP-1-class agent in obesity to date. — Jastreboff et al. Phase 2 trial, NEJM 2023
    Retatrutide 12 mg reduced HbA1c by approximately 2.02 percentage points at 36 weeks in patients with type 2 diabetes, compared with 1.41 points on dulaglutide 1.5 mg. — Rosenstock et al. Phase 2 T2D trial, Lancet 2023

    Key Takeaways

    • Retatrutide 12 mg produced a mean body weight reduction of approximately 24.2% at 48 weeks in adults with obesity in a Phase 2 trial — the highest published mean weight reduction for any GLP-1-class agent in obesity to date. (Source: Jastreboff et al. Phase 2 trial, NEJM 2023)
    • Retatrutide 12 mg reduced HbA1c by approximately 2.02 percentage points at 36 weeks in patients with type 2 diabetes, compared with 1.41 points on dulaglutide 1.5 mg. (Source: Rosenstock et al. Phase 2 T2D trial, Lancet 2023)
    • Retatrutide is investigational and not FDA-approved as of publication. Trial findings reported here are from Phase 2 / Phase 3 studies in peer-reviewed sources cited below.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: May 18, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Kaplan LM, Frías JP, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2301972
    2. Rosenstock J, Frias J, Jastreboff AM, et al. (2023). Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial. The Lancet.Read StudyDOI: 10.1016/S0140-6736(23)01053-X
    3. ClinicalTrials.gov (2024). A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Are Overweight (TRIUMPH-1) — NCT05929066. ClinicalTrials.gov.Read Study
    4. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    5. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    6. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Detailed comparison of retatrutide vs orforglipron: injectable triple agonist vs the first oral GLP-1 pill. Weight loss data, convenience, side effects, and which might be right for you.

    How much walking should you do on retatrutide? Evidence-based walking guidelines for GLP-1 weight loss patients, including step targets, intensity recommendations, and tips for managing side effects.

    What to expect in your first month on retatrutide: realistic weight loss expectations, side effects, appetite changes, and tips for maximizing early results during the dose titration phase.

    Start your GLP-1 journey — from $99/mo

    Get Started